ENT manifestations of Sjogren's syndrome: A narrative review

Authors

  • Amulya T M Department of Clinical Immunology and Rheumatology, JSS Medical College, JSS Academy of Higer Education and Research, Mysuru, Karnataka, India
  • G Nivetha Devi Department of Clinical Immunology and Rheumatology, JSS Medical College, JSS Academy of Higer Education and Research, Mysuru, Karnataka, India
  • Mahabaleshwar Mamadapur Department of Clinical Immunology and Rheumatology, JSS Medical College, JSS Academy of Higer Education and Research, Mysuru, Karnataka, India
  • Varuni Pragya Department of Clinical Immunology and Rheumatology, JSS Medical College, JSS Academy of Higer Education and Research, Mysuru, Karnataka, India

DOI:

https://doi.org/10.15305/ijrci/v12i1/387

Abstract

Sjogren's syndrome (SS) is an autoimmune condition marked by dryness of the mouth and eyes, frequently manifesting as a range of ENT symptoms that have a major negative impact on the quality of life of patients. Dryness and discomfort in the mouth and eyes, brought on by lacrimal and salivary gland dysfunction, are ENT symptoms in SS. However, ENT regions are involved in more areas than just the ocular surface and mouth cavity. Due to laryngopharyngeal involvement, patients may experience hoarseness, dysphagia, and the sensation that something foreign is in their throat. Common nasal symptoms include nasal dryness, congestion, and recurrent sinusitis, while Eustachian tube dysfunction can lead to middle ear infections and hearing problems. To improve the quality of life in SS patients, clinicians and healthcare professionals should be careful in identifying and treating these symptoms. More investigations and clinical trials are required to create tailored medicines that can reduce ENT symptoms and enhance long-term outcomes for SS patients.

Downloads

Published

05-03-2024

Issue

Vol. 12 No. 1 (2024)

Section

Reviews

License

Copyright for articles published in this journal is retained by the authors, with first publication rights granted to the ‘Internet Journal of Rheumatology and Clinical Immunology’. All the published content, except where otherwise noted, is licensed under Creative Commons license (CC-BY).

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) after the publication of the manuscript in IJRCI, as it can lead to productive exchanges, as well as earlier and greater citation of published work.